Pseudolaric Acid B Circumvents Multidrug Resistance Phenotype in Human Gastric Cancer SGC7901/ADR Cells by Downregulating Cox-2 and P-gp Expression

Cell Biochemistry and Biophysics

Volumn 71, Issue 1, 2015, Pages 119-126

  Yu, Fei ^a   Li, Kai ^a   Chen, Suning ^a   Liu, Yunpeng ^a   Li, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Gastric cancer; Multidrug resistance; P glycoprotein; Pseudolaric acid B

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; DITERPENE; MULTIDRUG RESISTANCE PROTEIN; PSEUDOLARIC ACID B;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECTS; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; PHENOTYPE; STOMACH TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLOOXYGENASE 2; DITERPENES; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; HUMANS; P-GLYCOPROTEIN; PHENOTYPE; STOMACH NEOPLASMS;

EID: 84939879917     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0170-7     Document Type: Article

References (30)

1. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10 [Internet]. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr (2 December 2011, date last accessed).
2. Sun, X. D., Mu, R., Zhou, Y., Dai, X., Qiao, Y., Zhang, S., et al. (2002). 1990–1992 mortality of stomach cancer in China. Chinese Journal of Oncology,24, 4–8.
3. Labialle, S., Gayet, L., Marthinet, E., Rigal, D., & Baggetto, L. G. (2002). Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochemical Pharmacology,64, 943–948.
4. Steinbach, D., & Legrand, O. (2007). ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia,21, 1172–1176.
5. Mignogna, C., Staibano, S., Altieri, V., De Rosa, G., Pannone, G., Santoro, A., et al. (2006). Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: A 5 year follow-up analysis. BMC Cancer,6, 293.
6. Gayet, L., Dayan, G., Barakat, S., Labialle, S., Michaud, M., Cogne, S., et al. (2005). Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Biochemistry,44, 4499–4509.
7. Nardone, G., Rocco, A., Vaira, D., Staibano, S., Budillon, A., Tatangelo, F., et al. (2004). Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: A molecular pathway of H pylori-related gastric carcinogenesis. The Journal of Pathology,202, 305–312.
8. Zhang, Y., Qu, X., Hu, X., Yang, X., Hou, K., Teng, Y., et al. (2009). Reversal of P-glycoprotein-mediated multidrug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells. The Journal of Pathology,218, 248–255.
9. Xu, H. W., Xu, L., Hao, J. H., Qin, C. Y., & Liu, H. (2010). Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer. Journal of International Medical Research,38, 34–42.
10. Liu, W., Yu, Y. H., Ouyang, X. N., & Wang, L. (2010). Clinical significance of P-glycoprotein and topoisomerase II expression in gastric cancer. The World Journal of Gastroenterology,18, 3640–3647.
11. Wu, Y.-M., Chen, J., Xiong, X.-S., Cervello, M., & Montalto, G. (2006). Cyclooxygenases in hepatocellular carcinoma. World Journal of Gastroenterology,12, 5113–5121.
12. Liu, B., Qu, L., & Tao, H. (2009). Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance. Cell Biology International,34, 21–25.
13. Patel, V. A., Dunn, M. J., & Sorokin, A. (2002). Regulation of MDR-1/P-glycoprotein by cyclooxygenase-2. Journal of Biological Chemistry,277, 38915–38920.
14. Uefuji, K., Ichikura, T., & Mochizuki, H. (2001). Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. Journal of Surgical Oncology,76, 26–30.
15. Xu, Y. H., Zhao, L. J., & Li, Y. (2009). Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World Journal of Gastroenterology,15, 2870–2877.
16. Ju, X. H., Xu, Y. H., & Li, Y. (2008). Effects of pseudolaric acid B on the apoptosis, mitochondrial membrane potential and cyclooxygenase-2 expression in hepatocellular carcinoma cell line BEL-7402. World Journal of Gastroenterology,16, 1151–1156.
17. Yu, J. H., Wang, H. J., Li, X. R., Tashiro, S., Onodera, S., & Ikejima, T. (2008). Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells. Acta Pharmacologica Sinica,29, 1069–1076.
18. Yu, J., Li, X., Tashiro, S., Onodera, S., & Ikejima, T. (2008). Bcl-2 family proteins were involved in pseudolaric acid B-induced autophagy in murine fibrosarcoma L929 cells. Journal of Pharmacological Sciences,107, 295–302.
19. Yu, J. H., Cui, Q., Jiang, Y. Y., Yang, W., Tashiro, S., Onodera, S., et al. (2007). Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF-7. Acta Pharmacologica Sinica,28, 1975–1983.
20. Wu, W. Y., Guo, H. Z., Qu, G. Q., Han, J., & Guo, D. A. (2006). Mechanisms of pseudolaric acid B-induced apoptosis in bel-7402 cell lines. American Journal of Chinese Medicine,34, 887–899.
21. Gong, X., Wang, M., Tashiro, S., Onodera, S., & Ikejima, T. (2006). Involvement of JNK-initiated p53 accumulation and phosphorylation of p53 in pseudolaric acid B induced cell death. Experimental & Molecular Medicine,38, 428–434.
22. Liu, B., Chen, H., Lei, Z. Y., Yu, P. F., & Xiong, B. (2006). Studies on anti-tumour activities of pseudolaric acid-B (PLAB) and its mechanism of action. Journal of Asian Natural Products Research,8, 241–252.
23. Li, K. S., Gu, X. F., Li, P., Zhang, Y., Zhao, Y. S., Yao, Z. J., et al. (2005). Effect of pseudolaric acid B on gastric cancer cells: inhibition of proliferation and induction of apoptosis. World Journal of Gastroenterology,11, 7555–7559.
24. Qi, M., Yao, G., Fan, S., Cheng, W., Tashiro, S., Onodera, S., et al. (2012). Pseudolaric acid B induces mitotic catastrophe followed by apoptotic cell death in murine fibrosarcoma L929 cells. European Journal of Pharmacology,683, 16–26.
25. Tong, J., Yin, S., Dong, Y., Guo, X., Fan, L., Ye, M., et al. (2013). Pseudolaric acid B induces caspase-dependent apoptosis and autophagic cell death in prostate cancer cells. Phytotherapy Research,27, 885–891.
26. Ko, J. K., Leung, W. C., Ho, W. K., & Chiu, P. (2007). Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene. European Journal of Pharmacology,559, 1–13.
27. Li, Y. (2009). Foundation and clinical research on the effect of traditional chinese herb on gastrointestinal motility. Chinese Journal of Integrative Medicine,15, 86–88.
28. Wong, V. K., Chiu, P., Chung, S. S., Chow, L. M., Zhao, Y. Z., Yang, B. B., et al. (2005). Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clinical Cancer Research,11, 6002–6011.
29. Ma, G., Chong, L., Li, X. C., Khan, I. A., Walker, L. A., & Khan, S. I. (2010). Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B. Journal of Cancer Research and Clinical Oncology,136, 1333–1340.
30. Meng, A. G., & Jiang, L. L. (2009). Pseudolaric acid B-induced apoptosis through p53-dependent pathway in human gastric carcinoma cells. Journal of Asian Natural Products Research,11, 142–152.